Health Benefits

Botox vs. Dysport: Contraindications to Their Use

There is no woman who does not care about her appearance. It is amazing what representatives of the gentle sex do to look good, but sooner or later, time takes its toll, facial lines and wrinkles give out the age that has to be carefully hidden with various tricks. In this case, derivatives of botulinum toxin type A come to the aid. The most popular beauty products on the market are Botox produced by Allergan (USA) and Dysport by Ipsen (France). The brand Botox appeared on the pharmaceutical market earlier.  Currently, only Dysport (look for Dysport online here) is competing with it. 

Undoubtedly, having a choice at their disposal, patients are interested in the advantages and disadvantages of each of the preparation, as well as contraindications to their use. We will try to help you grasp this.

Botox and Dysport are botulinum toxins purified and diluted to a safe concentration. Injected with a tiny needle into particular points of the mimic muscles, botulinum toxin causes relaxation and, as a result, eliminates the cause of wrinkling. The blood supply to the muscles is not affected.

When Botox and Dysport are not Advisable

There are no age limits for both medications. The quality of licensed products is very high, but there are certain contraindications for their use.

It is absolutely forbidden to use them in patients suffering from:

Pregnancy and a period of lactation are also absolute contraindications.

Relative contraindications include taking some medications. Botulinum toxin administration should be restricted given the following groups of drugs are being used:

Side Effects

Complications can be associated:

Fortunately, all the side effects that can occur after injections of botulinum toxin are completely reversible and they disappear within 3-4 weeks.

And finally, you should be aware that there are no proven long-term negative effects of Botox and Dysport procedures. Neurotoxin is completely eliminated 7-9 months later.

Comments

comments

Exit mobile version